See also this year's filing and all EDGAR filings for this company.
PDF Report 0001048477_2020_BIOMARIN_PHARMACEUTICAL_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001048477, BIOMARIN PHARMACEUTICAL INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,942,143,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 653,619,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,010,868,000 |
| 3 | remainder_Assets | 1,083,409,000 |
| 4 | LiabilitiesCurrent | 932,503,000 |
| 5 | LiabilitiesNoncurrent | 98,124,000 |
| 6 | remainder_Liabilities | 537,031,000 |
| 7 | CostOfGoodsAndServicesSold | 359,466,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 680,924,000 |
| 9 | ResearchAndDevelopmentExpense | 715,007,000 |
| 10 | remainder_Expenses | 1,605,000 |
| 11 | remainder_Revenues | 1,704,048,000 |
| 12 | remainder_NetIncome | 29,106,000 |
| 13 | remainder_ComprehensiveNetIncome | 14,893,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,690,039,000 |
| 1 | Liabilities | 1,567,658,000 |
| 2 | Expenses | 1,757,002,000 |
| 3 | Revenues | 1,704,048,000 |
| 4 | StockholdersEquity | 3,122,381,000 |
| 5 | NetIncome | -23,848,000 |
| 6 | ComprehensiveNetIncome | -16,401,500 |
| 7 | BaseVar | 4,881,373,000 |
| 8 | EconomicCapitalRatio | 1.71 |
Edgar->Model Mapping
Feature Distribution
Change over Time
